This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Viventia Bio Inc.
Drug Names(s): VB6845d, VB6 845d
Description: VB6-845d is a targeted protein therapeutic (TPT) consisting of an EpCAM targeting Fab antibody fragment genetically fused to the de-immunized cytotoxic protein payload, deBouganin.
Pink Sheet Weekly Trademark Review April 22, 2014
Pink Sheet Weekly Trademark Review May 21, 2013
Pink Sheet Chart: Weekly Trademark Review
Additional information available to subscribers only: